These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 18287934

  • 21. The ups and downs of BDNF in Rett syndrome.
    Sun YE, Wu H.
    Neuron; 2006 Feb 02; 49(3):321-3. PubMed ID: 16446133
    [Abstract] [Full Text] [Related]

  • 22. Rett syndrome: of girls and mice--lessons for regression in autism.
    Glaze DG.
    Ment Retard Dev Disabil Res Rev; 2004 Feb 02; 10(2):154-8. PubMed ID: 15362175
    [Abstract] [Full Text] [Related]

  • 23. [Rett syndrome: clinical and molecular aspects].
    Záhoráková D, Zeman J, Martásek P.
    Cas Lek Cesk; 2007 Feb 02; 146(8):647-52. PubMed ID: 17874730
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms of disease: neurogenetics of MeCP2 deficiency.
    Francke U.
    Nat Clin Pract Neurol; 2006 Apr 02; 2(4):212-21. PubMed ID: 16932552
    [Abstract] [Full Text] [Related]

  • 25. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome.
    Nag N, Mellott TJ, Berger-Sweeney JE.
    Brain Res; 2008 Oct 27; 1237():101-9. PubMed ID: 18778693
    [Abstract] [Full Text] [Related]

  • 26. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized.
    Bienvenu T, Chelly J.
    Nat Rev Genet; 2006 Jun 27; 7(6):415-26. PubMed ID: 16708070
    [Abstract] [Full Text] [Related]

  • 27. Rett syndrome: prevalence among Chinese and a comparison of MECP2 mutations of classic Rett syndrome with other neurodevelopmental disorders.
    Wong VC, Li SY.
    J Child Neurol; 2007 Dec 27; 22(12):1397-400. PubMed ID: 18174559
    [Abstract] [Full Text] [Related]

  • 28. Identification of cis-regulatory elements for MECP2 expression.
    Liu J, Francke U.
    Hum Mol Genet; 2006 Jun 01; 15(11):1769-82. PubMed ID: 16613900
    [Abstract] [Full Text] [Related]

  • 29. Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome.
    Belichenko NP, Belichenko PV, Li HH, Mobley WC, Francke U.
    J Comp Neurol; 2008 May 01; 508(1):184-95. PubMed ID: 18306326
    [Abstract] [Full Text] [Related]

  • 30. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
    Tao J, Wu H, Sun YE.
    Int Rev Neurobiol; 2009 May 01; 89():147-60. PubMed ID: 19900619
    [Abstract] [Full Text] [Related]

  • 31. Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.
    Ben-Zeev B, Aharoni R, Nissenkorn A, Arnon R.
    Med Hypotheses; 2011 Feb 01; 76(2):190-3. PubMed ID: 20951500
    [Abstract] [Full Text] [Related]

  • 32. Rett syndrome: a prototypical neurodevelopmental disorder.
    Neul JL, Zoghbi HY.
    Neuroscientist; 2004 Apr 01; 10(2):118-28. PubMed ID: 15070486
    [Abstract] [Full Text] [Related]

  • 33. The transcriptional repressor Mecp2 regulates terminal neuronal differentiation.
    Matarazzo V, Cohen D, Palmer AM, Simpson PJ, Khokhar B, Pan SJ, Ronnett GV.
    Mol Cell Neurosci; 2004 Sep 01; 27(1):44-58. PubMed ID: 15345242
    [Abstract] [Full Text] [Related]

  • 34. Rett syndrome: from the gene to the disease.
    Matijevic T, Knezevic J, Slavica M, Pavelic J.
    Eur Neurol; 2009 Sep 01; 61(1):3-10. PubMed ID: 18948693
    [Abstract] [Full Text] [Related]

  • 35. Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice.
    D'Cruz JA, Wu C, Zahid T, El-Hayek Y, Zhang L, Eubanks JH.
    Neurobiol Dis; 2010 Apr 01; 38(1):8-16. PubMed ID: 20045053
    [Abstract] [Full Text] [Related]

  • 36. DNA methylation and Rett syndrome.
    Kriaucionis S, Bird A.
    Hum Mol Genet; 2003 Oct 15; 12 Spec No 2():R221-7. PubMed ID: 12928486
    [Abstract] [Full Text] [Related]

  • 37. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
    Okabe Y, Kusaga A, Takahashi T, Mitsumasu C, Murai Y, Tanaka E, Higashi H, Matsuishi T, Kosai K.
    Brain Res; 2010 Nov 11; 1360():17-27. PubMed ID: 20816763
    [Abstract] [Full Text] [Related]

  • 38. Methyl-CpG-binding protein 2 (MECP2) gene mutations in an Italian sample of patients with pervasive developmental disorder and mental retardation.
    Parmeggiani A, Tedde MR, Arbizzani A, Posar A, Scaduto MC, Santucci M, Sangiorgi S.
    J Child Neurol; 2009 Jun 11; 24(6):772-4. PubMed ID: 19189931
    [Abstract] [Full Text] [Related]

  • 39. Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene.
    Bartholdi D, Klein A, Weissert M, Koenig N, Baumer A, Boltshauser E, Schinzel A, Berger W, Mátyás G.
    Clin Genet; 2006 Apr 11; 69(4):319-26. PubMed ID: 16630165
    [Abstract] [Full Text] [Related]

  • 40. Postnatal changes in serotonergic innervation to the hippocampus of methyl-CpG-binding protein 2-null mice.
    Isoda K, Morimoto M, Matsui F, Hasegawa T, Tozawa T, Morioka S, Chiyonobu T, Nishimura A, Yoshimoto K, Hosoi H.
    Neuroscience; 2010 Feb 17; 165(4):1254-60. PubMed ID: 19932741
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.